Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.78 |
| ▸ | LMNA | P02545 | 6/20 | 0.78 |
| ▸ | HPGD | P15428 | 5/20 | 0.78 |
| ▸ | MEN1 | O00255 | 3/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.78 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.78 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.76 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.76 |
| ▸ | ESR1 | P03372 | 1/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.69 |
| ▸ | ACP1 | P24666 | 1/20 | 0.69 |
| ▸ | PDE4A | P27815 | 1/20 | 0.69 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.69 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.69 |
| ▸ | PDXK | O00764 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 6/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridoxal SCHEMBL2223414 | 1.00 | KDM4E (0.78) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Triphosphate SCHEMBL28454699 | 0.95 | KDM4E (0.74) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL5051304 | 0.93 | KDM4E (0.72) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL27627958 | 0.91 | KDM4E (0.88) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL5498057 | 0.91 | KDM4E (0.88) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL30616198 | 0.91 | KDM4E (0.88) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL28454700 | 0.91 | KDM4E (0.88) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL9559097 | 0.91 | KDM4E (0.88) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL27131 | 0.91 | KDM4E (0.88) | KDM4EALDH1A1LMNAHPGDMEN1 | |
| Pyridoxal SCHEMBL5051301 | 0.91 | KDM4E (0.88) | KDM4EALDH1A1LMNAHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021126989-A1 | TWO-WAY MAGNETIC RESONANCE TUNING NANOPROBE ENHANCED SUBTRACTION IMAGING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-06-24 | — | — | WO | claimed |
| EP-2547369-B1 | A NANOPARTICLE COMPRISING A MICELLE FORMED BY AN AMPHIPHILIC BLOCK-COPOLYMER AND ENCAPSULATING A GADOLINIUM COMPLEX | UNIV KING SAUD (SA) | 2017-04-19 | — | — | EP | claimed |
| EP-2214718-B1 | LOADABLE POLYMERIC PARTICLES FOR ENHANCED IMAGING IN CLINICAL APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME | BOSTON SCIENT LTD (BM) | 2017-04-12 | — | — | EP | claimed |
| EP-2547369-A1 | A NANOPARTICLE COMPRISING A MICELLE FORMED BY AN AMPHIPHILIC BLOCK- COPOLYMER AND ENCAPSULATING A GADOLINIUM COMPLEX | King Saud University (SA) | 2013-01-23 | — | — | EP | claimed |
| WO-2011113616-A9 | A NANOPARTICLE COMPRISING A MICELLE FORMED BY AN AMPHIPHILIC BLOCK- COPOLYMER AND ENCAPSULATING A GADOLINIUM COMPLEX | KING SAUD UNIVERSITY (SA) | 2011-11-17 | — | — | WO | claimed |
| WO-2011113616-A1 | A NANOPARTICLE COMPRISING A MICELLE FORMED BY AN AMPHIPHILIC BLOCK- COPOLYMER AND ENCAPSULATING A GADOLINIUM COMPLEX | KING SAUD UNIVERSITY (SA) | 2011-09-22 | — | — | WO | claimed |
| EP-2214718-A1 | LOADABLE POLYMERIC PARTICLES FOR ENHANCED IMAGING IN CLINICAL APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME | CeloNova Biosciences, Inc. (US) | 2010-08-11 | — | — | EP | claimed |
| WO-2009067105-A1 | LOADABLE POLYMERIC PARTICLES FOR ENHANCED IMAGING IN CLINICAL APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME | CELONOVA BIOSCIENCES, INC. (US) | 2009-05-28 | — | — | WO | claimed |
| EP-3998336-B1 | MICROORGANISMS AND METHODS FOR PRODUCING CANNABINOIDS AND CANNABINOID DERIVATIVES | UNIV CALIFORNIA (US) | 2026-01-07 | — | — | EP | disclosed |
| US-12460185-B2 | Optimized cannabinoid synthase polypeptides | DEMETRIX, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12215327-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-04 | — | — | US | disclosed |
| US-12048710-B2 | Compositions and methods for modification of biomolecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-30 | — | — | US | disclosed |
| US-20230340506-A1 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-26 | — | — | US | disclosed |
| US-11542512-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-01-03 | — | — | US | disclosed |
| WO-2004064869-A2 | AMYLOID-BINDING, METAL-CHELATING AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2004-08-05 | — | — | WO | disclosed |
| US-6432918-B1 | SYNTHETIC BLOOD; SUPPLYING OXYGEN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-08-13 | — | — | US | disclosed |
| CN-1300824-A | Polypeptide-serine/threonine dehybase 37 and polynucleotide for coding this polypeptide | UNIV FUDAN (CN) | 2001-06-27 | — | — | CN | disclosed |
| EP-0598837-A4 | AMINO ACID, ESTER AND/OR CATECHOL CONTRAST AGENTS FOR MRI. | UNIV CALIFORNIA (US) | 1994-07-13 | — | — | EP | disclosed |
| EP-0598837-A1 | AMINO ACID, ESTER AND/OR CATECHOL CONTRAST AGENTS FOR MRI | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-06-01 | — | — | EP | disclosed |
| WO-1993003351-A1 | AMINO ACID, ESTER AND/OR CATECHOL CONTRAST AGENTS FOR MRI | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12048710-B2 | Compositions and methods for modification of biomolecules | PTMS, QPCT, ANPEP | KDM4E 3669/4885ALDH1A1 3718/4885LMNA 1871/4885 |
| US-11542512-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | CNR2, CNR1, FAAH | KDM4E 913/4885ALDH1A1 2306/4885LMNA 4339/4885 |
| US-12215327-B2 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | CNR2, CNR1, FAAH | KDM4E 913/4885ALDH1A1 2306/4885LMNA 4339/4885 |
| US-20230340506-A1 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | CNR2, CNR1, FAAH | KDM4E 913/4885ALDH1A1 2306/4885LMNA 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.